Anticipated Adverse Events If a subject experiences adverse events, subjects will be closely monitored every hour until the event resolves. Adverse event duration and resolution time will be recorded. If the adverse event resolves, the next scheduled dose will be reduced by 33%. Each adverse event will be assessed by the Principal Investigator and a clinical relevance determination will be made.